Those include but are not limited to drug-induced pneumonitis associated with mTOR inhibitors, immune checkpoint inhibitor therapy-related pneumonitis [95], severe viral pneumonia, radiation pneumonitis, and eosinophilic pneumonia associated with chimeric antigen receptor T cell (CAR T) therapy [96]. Here, MTOR is linked to eosinophilic pneumonia.